AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitasmart-M 50/1000 Tablet

Prescription Icon
Prescription Required

Marketer

Healing Pharma India Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Sitasmart-M 50/1000 Tablet

Diabetics with type 2 mellitus may find relief from elevated blood glucose levels with the dual-action formulation of Sitasmart-M 50/1000 Tablet. This medication mitigates the risk of severe diabetic complications, including renal impairment and vision loss, and may lessen the likelihood of cardiovascular events. Sitasmart-M 50/1000 Tablet can be administered independently or in conjunction with other anti-diabetic therapies. Optimal efficacy is achieved with concurrent adherence to a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glycemic control, and concomitant medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefit, and discontinuation should only occur under physician guidance. Maintaining the prescribed diet and exercise plan is crucial for effective diabetes management, as lifestyle significantly impacts glycemic control. Commonly reported side effects encompass diarrhea, nausea, emesis, dyspepsia, cephalalgia, and pharyngitis. Hypoglycemia, a potential adverse event, particularly when combined with insulin or sulfonylureas, necessitates patient awareness of its symptoms and management. This medication is not universally suitable. Individuals with pre-existing renal, hepatic, or cardiac conditions, pancreatic dysfunction, or significant alcohol consumption should inform their physician prior to commencement. Pregnant or lactating women require medical consultation before initiating therapy. Potential drug interactions necessitate a comprehensive medication review with your doctor to ensure treatment safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Regular monitoring of renal function and blood glucose levels will be conducted by your physician throughout treatment.

Uses of Sitasmart-M 50/1000 Tablet

Managing type 2 diabetes

Major Benefits of Sitasmart-M 50/1000 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Sitasmart-M 50/1000 Tablet with a meal.

Common Side effects of Sitasmart-M 50/1000 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitasmart-M 50/1000 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sitasmart-M 50/1000 tablets should be administered with a meal.

How Sitasmart-M 50/1000 Tablet works:

Sitasmart-M 50/1000 tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and boosts insulin sensitivity. This dual action optimizes blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitasmart-M 50/1000 Tablet with alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sitasmart-M 50/1000 tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against the risks prior to prescribing. Medical advice is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitasmart-M 50/1000 tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Sitasmart-M 50/1000 Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Sitasmart-M 50/1000 Tablets. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

The use of Sitasmart-M 50/1000 Tablet is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitasmart-M 50/1000 Tablet :

Should you forget to take your Sitasmart-M 50/1000 Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Sitasmart-M 50/1000 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitasmart-M 50/1000 Tablet

Sitasmart-M 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Sitasmart-M 50/1000 tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left untreated. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitasmart-M 50/1000 Tablet may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitasmart-M 50/1000 Tablets are contraindicated in patients with allergies to any ingredient, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitasmart-M 50/1000 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (like Sitasmart-M 50/1000) can rarely cause lactic acidosis (MALA), a serious medical emergency involving high blood lactic acid levels. This risk is increased in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If experienced, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitasmart-M 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitasmart-M 50/1000 Tablet may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Sitasmart-M 50/1000 Tablets are contraindicated in patients with known allergies to any ingredient or excipient. This medication should also be avoided in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitasmart-M 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin + Metformin (like Sitasmart-M 50/1000) can rarely cause lactic acidosis (MALA), a serious medical emergency involving high blood lactic acid levels. This risk is higher in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms may include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or slow heart rate. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Sitasmart-M 50/1000 tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including balance problems). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Sitasmart-M 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is unsuitable for individuals under 18.
Sitasmart-M 50/1000 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infection. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitasmart-M 50/1000 Tablets are contraindicated in patients with known allergies to any ingredient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitasmart-M 50/1000 tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Sitagliptin + Metformin (like Sitasmart-M 50/1000) can rarely cause lactic acidosis (MALA), a serious medical emergency due to excessive blood lactic acid. This risk is higher in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Sitasmart-M 50/1000 tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitasmart-M 50/1000 Table...
290
MRP 336
13% off